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Recent studies on transplantable reticulum cell sarcomas (RCS) 1 in syngeneic SJL/J 
mice have demonstrated that these lymphoma cells induce a marked degree of prolifera- 
tion in peripheral T and thymus cells from normal SJL/J mice (1) without any accompa- 
nying development of cytotoxic cells in vitro (2).  The nature of the antigen inducing this 
proliferation is unclear. No presensitization to the antigen appears needed for the cells to 
respond since thymus and spleen cells from neonatal mice give a  definite response even 
before reactivity to allogeneic spleen cells is detected.  2 Nevertheless, the possibility exists 
that virally induced antigens on the RCS cells are involved, particularly since SJL/J mice 
have been suggested to harbor leukemia virus which can induce RCS in BALB/c mice (3) 
and in F~ mice of the SJL/J strain (4). 
Antigens known to induce high proliferative responses without an apparent need for 
previous sensitization are Ia antigens of the H-2  complex and antigens specified by the 
Mls locus in mouse strains. The response of SJL/J cells to RCS develops faster in vitro 
than  the  one  to  alloantigens  and  is  higher  in  magnitude  (1,  2).  In  other  respects, 
responses to RCS  cells resemble the primary responses to Ia antigens or to Mls-locus 
antigens which, in the absence of other antigenic differences, are also known to be low or 
negative for cytotoxic cell development (5-7). The nature of the antigen-inducing synge- 
neic responses, such as that of normal thymus cells to spleen (8) or lymph node (9) cells is 
unknown,  but  the  proliferation  induced  in  this  situation  is  also  unaccompanied  by 
cytotoxic cell development. In all these cases, B lymphocytes (and macrophages) bear the 
antigens  responsible for the  stimulation of T  cells,  which  possibly brings  in  another 
similarity since primary RCS  is said to arise in germinal centers  (10)  and 3H-labeled 
transplantable RCS cells localize in splenic and lymph node follicles (11) and thus may be 
B-cell derived. It has also been suggested that RCS cells are Thy 1- and Ia+ but do not 
exhibit cell surface Ig or any other B-cell surface marker (2).  It is not known, however, 
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whether primary RCS cells are already able to stimulate T  cells into proliferation or 
whether this is 8 property acquired after several transplantations. 
In the  present studies it will be demonstrated that primary  RCS  cells also 
stimulate T  cells and that transplantable  RCS cells bear Ia antigens on their 
surface.  Incorporation of antisera  to  Iz  antigens  of the  SJL/J  strain  in  the 
medium  appears  to  block  the  ability of these  cells  to  induce a  proliferative 
response, without affecting the ability of SJL/J T  cells to respond to allogeneic 
cells or nonspecific stimuli. 
Materials  and  Methods 
Mice and Tumors.  Female SJL/J and male BALB/c mice were purchased from The Jackson 
Laboratory, Bar Harbor, Maine. ASW, B. 10S, A.TH, and A.TL mice were bred in the Washington 
University laboratories. 
The RCS tumors utilized in these studies were derived from spontaneous RCS in SJL/J mice 
(12). The transplantable RCS tumors (RCS-5 and RCS-19) were maintained in serial passage by 
transfer of 107 tumorous lymph node cells into syngeneic mice at regular intervals. 
Antisera.  Anti-Thy 1.2 was a generous gift of Dr. L. J. Old and Ms. E. A. Carswell from the 
Sloan-Kettering  Institute for Cancer Research,  New York, and was prepared by immunization  of 
(A/Thy 1.1 × AKR/H-2 b)Fl mice with the A strain leukemia ASL-1 (13). Rabbit anti-mouse Ig was 
prepared by immunization with 0.5 mg of Fab fragments of mouse Ig and complete  Freund's 
adjuvant as previously described  (14). Five anti-Ia sera and one anti-H-2.19 serum were employed 
in these studies.  The specific  strain combinations for  antiserum production are listed in the 
respective tables.  All six  antisera were  produced  by the  immunization procedure  described 
previously by David et al. (15). 
Cultures.  Lymphocyte  cultures were prepared in flat-bottomed Linbro tissue culture plates 
(IS-FB-96-TC; Linbro Scientific Co.,  New  Haven, Conn.) in RPMI-1640 (Associated  Biomedic 
Systems, Inc., Buffalo,  N.  Y.) with 10% fetal calf serum (Grand Island Biological  Co.,  Grand 
Island, N. Y.) and 5 x  10  -5 M 2-mercaptoethanol (Eastman Kodak Co., Rochester,  N. Y.). Cells 
used for stimulation of a proliferative response were either irradiated (RCS cells, 6000 R; alloge- 
neic lymphocytes, 1,500 R) from a ~37cesium  source  (Radiation International  Inc., Parsippany, N. 
J.) or treated with 25 ~g/ml mitomycin C (Drug Development Branch, National Cancer Institute, 
Bethesda, Md.) for 30 min at 37°C and washed three times before culture. Optimal stimulation  was 
obtained using 2 x  105 responder cells and either 5 x  104 irradiated RCS tumor cells or 2 × 105 
irradiated allogeneic lymphoid cells per well.  In some  experiments, nonspecific  stimuli were 
utilized as a measure of lymphocyte reactivity. These included incubation  with concanavalin  A (5 
ftg/ml: Miles-Yeda, Ltd., Rehovot, Israel), phytohemagglutinin  (PHA-P, 5 ~g/ml; Difco Laborato- 
ries, Detroit, Mich.), and lipopolysaccharide (20 ftg/ml: Difco Laboratories) for 72 h. One ~tCi 3H- 
thymidine (Schwarz/Mann Div., Becton,  Dickinson & Co.,  Orangeburg, N.  Y.; sp act 0.36 Ci/ 
mmol) was added to each well 24 h before collection of cultures on glass fiber filters (Reeve Angel, 
Clifton, N. J.) with an automated cell harvester. Filters from five replicate cultures were counted 
in a Packard Tri-Carb Scintillation Counter (Packard Instrument Co., Inc., Downers Grove, Ill.) 
using Scintiverse liquid scintillation cocktail (Fisher Scientific Co., Fairlawn, N. J.). 
Ficoll-Isopaque  Gradients.  Continuous  Ficoll-Isopaque (Ficoll 400; Pharmacia Fine Chemicals 
Ltd.,  Uppsala,  Sweden and Isopaque-Sodium Metrozoate;  Gallard-Schlesinger Chemical Mfg. 
Corp.,  Carl Place, N. Y.) density gradients were prepared according to Loos and Roos (16). RCS 
cells derived from lymph nodes (LN) of tumorous SJL/J mice were layered on top of the gradient 
and tubes were spun for 20 rain at 2,400 rpm at 4°C. 1-ml fractions were collected by inserting a 
long needle to the bottom of the gradient tube and pumping the contents through an automatic 
fraction collector  (LKB Instruments, Inc., Rockville,  Md.). 
The optical density of each fraction was determined and found to be linear. Cell counts in each 
fraction were performed using a  Coulter Counter Model B  (Coulter Electronics Inc., Hialeah, 
Fla.), and a  graph was prepared plotting cell  number versus fraction number, which showed 
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the peak densities obtained from the graph,  and RCS  cells separated  on such gradients were 
utilized in the studies reported here. 
Antibody-Mediated Cytotoxicity.  Antisera directed against various membrane antigens were 
tested for their ability to lyse target cells in the presence of complement (C) by a  modification of 
the microcytotoxicity test developed by Mittal et al.  (17).  2  ~1 of the antisera to be tested was 
serially diluted in wells of'Terasaki" microtest plates (no. 3034 Falcon Plastics, Div. of BioQuest, 
Oxnard, Calif.) 2 ~l of target cells were added to each well and the plates were incubated at 37°C 
for 20 min. For one-stage testing, C' was added directly to wells, while in the two-stage test plates 
were "flicked," to remove unbound antisera, C was added to each well, and incubation continued 
for an additional 30 rain at 37°C.  In both types of testing, after incubation with C, plates were 
flicked, trypan blue added,  and percent cytotoxicity determined by microscopic examination for 
uptake of dye into damaged cells. 
Appropriate controls, i.e. cells incubated with antibody or C alone, showed levels of cytotoxicity 
<10%.  In all cases the C  was absorbed twice with agarose in the presence of EDTA to remove 
nonspecific cytotoxicity before use (18,  19). 
In  treating  lymphoid  cells  and  tumor  cells  with  various  antisera  before  culture,  similar 
methods were employed in 17 x  100 mm tubes to accommodate larger numbers of cells. Killed cells 
were removed on a simple Ficoll-Hypaque gradient (densities 1.0750-1.0782) before use of the cells 
as stimulators or responders in cultures. 
Results 
Proliferative  Response  of SJL/J LN  Cells to  Primary  and  Transplantable 
RCS.  A few primary RCS which spontaneously developed in LN of 8- to 12-mo- 
old SJL/J mice were tested for their ability to induce proliferation in normal 
syngeneic lymphoid cells. The results in Table I  show a  definite proliferative 
response to 6,000  R ~/-irradiated RCS cells of primary tumor origin when the 
tumor  cell  to  normal  LN  cell  ratio  in  the  cultures  was  1:1  or  1:2  in  both 
experiments. Far fewer stimulating RCS cells were needed when the transplant- 
able RCS-5 tumor line was used, which actually stimulated better at ratios of 1:4 
than  at  1:1  and  indeed  even  with  ratios  as  low  as  1:8  and  1:10 excellent 
stimulation was obtained. 
Stimulation of normal SJL/J cells by RCS was not obtained when the tumor 
cell  types were  separated  by  a  Millipore  or  dialysis membrane  such  as  in 
Marbrook chambers.  This indicates that stimulation is  not due to  a  soluble 
mediator secreted by or liberated from tumor cells, as was also shown previously 
by the lack of stimulation with tumor cell supernates (1). It was concluded that 
cell contact appeared necessary for stimulation to occur. 
To characterize further the stimulating cell population in RCS, with respect to 
cell density, Ficoll-Isopaque separation of the tumor cells was performed before 
culture. In preliminary experiments with continuous density gradients, it was 
noted that tumor cells peaked at densities of 1.0660 and 1.0694. Discontinuous 
gradients were then prepared  to obtain fractions at these  as  well as higher 
densities and the proliferative response of normal LN cells to each fraction was 
determined (Table II). 
Although stimulation was obtained even with the highest density fraction, 
the  lowest density cells  were  clearly the  most effective stimulators in both 
experiments. 3H-thymidine incorporation in unirradiated cells from each frac- 
tion was also studied and found highest in the lowest density fraction over the 
first 24 h in culture (data not shown). When aliquots from each fraction (2 x  106) 
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TABLE  I 
Comparison of Response of Normal SJL/J LN Cells to T-Irradiated 
Lymphoma Cells from Spontaneous (Primary) Syngeneic RCS and from 
Serially  Transplanted  RCS-5 
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Stimulator cells  Ratio* of RCS/LN 
h cpm (SI)$ 
Exp. 1  Exp. 2 
Spontaneous RCS 
Transplanted RCS-5 
2:1  -  20,261  (49.0) 
1:1  2,312  (36.6)  12,074  (101.6) 
1:2  649  (7.8)  5,232  (79.1) 
1:4  155  (4.3)  2,461  (39.4) 
1:8  44  (1.8)  1,015  (16.9) 
1:1  748  (1.3)  12,862  (13.3) 
1:2  4,986  (3.4)  13,812  (15.2) 
1:4  7,704  (5.5)  14,456  (16.8) 
1:8  -  12,857  (15.3) 
1:10  10,190  (8.5)  - 
* RCS/LN ratio based on a constant number ofresponder SJL/J LN cells (2 × l0  s) and 
various numbers of RCS tumor cells cultured for 96 h in 0.2 ml in microplates. ~H- 
thymidine (1 ftCi) was added during the last 24 h of culture. 
$ h  clam, cpm in mixed cultures minus background cpm of responder LN cells and 
RCS stimulator cells cultured separately. SI, stimulation index, given in parenthe- 
ses, calculated by dividing the cpm in mixed cultures by the addition of cpm in 
responder and stimulator cells cultured separately. 
TABLE  II 
Response of SJL/J LN Cells to T-Irradiated Syngeneic Ficoll-Isopaque 
Gradient Separated RCS-5 Cells 
Fraction  of  7-RCS  Density 
A cpm (SI)* 
Exp. 1  Exp. 2 
Unfractionated  -  7,073 (17.6)  7,704 (5.5) 
Fraction A  1.0660  9,275 (22.6)  8,868 (6.7) 
B  1.0694  7,333 (14.8)  12,104 (8.1) 
C  1.0750  5,949 (14.6)  6,997 (5.3) 
D  1.0782  5,263 {14.6)  7,838 (5.7) 
E  1.0820  3,207 (9.8)  5,419 (4.5) 
* A cpm, cpm in mixed cell cultures minus background cpm of responder LN 
cells and RCS stimulator cells cultured separately. SI, stimulation index, 
given in parentheses, calculated by dividing the cpm in mixed cultures by 
the addition of cpm in responder and stimulator cells cultured separately. 
the same  degree of tumor  growth as judged by enlargement  of LN and spleen 7 
days later. 
Stimulation of  Normal LN Cells from Other H-2" Mouse Strains by RCS Cells 
of SJL/J Origin.  It  is  known  that  strong  proliferation  may  result  from  the 
mixing in culture of lymphoid cells from two mouse strains differing at the Mls 
locus (20). Mice of the B10 background  (B10.S) have a  nonstimulatory  ("silent") 
Mls-locus antigen  differing from the  one  in  SJL/J  and  A.SW  mice  (21).  Since 
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TABLE III 
Proliferative Response of LN Cells from Different H-2" Strains to RCS of SJL/J Origin 
Strain (re-  h cpm ± SE (n) in cultures* stimulated by:  %  SJL/J 
sponder LN  response 
cells)  SJL/J  RCS  BALB/c  C57BL/6*  to RCS 
SJL/J  -  13,244  -  1,071 (24)  2,923  +  1,508 (4)  - 
ASW  276  (2)  5,355  (2)  3,770  (2)  - 
B10.S  196  ±  107  (3)  2,516  ±  774  (4)  4,590  +- 780  (3)  - 
A.TH  454  -+ 1,772 (3)  6,197  ±  1,841 (4)  2,488  (1)  9,184 ±  4,407 (3) 






* Microplate cultures consisted of  2 × 105 responder LN cells  together with 5 × 104 RCS cells (6,000  R), or 2 x 10  s  SJL/J or BALB/c 
spleen cells  (1,500  R) in 0.2 ml medium for 96 h, the last  24 of  which were in the presence of i #tCi  SH-thymidine.  h cpm, cpm in 
mixed cultures minus background cpm of  responder LN cells  and stimulator RCS or spleen cells  cultured separately. Background 
cpm of responder cells  varied from approximately 300-1,600. 
Responses to C67BL/6 spleen cells  were probably  somewhat  higher than to other allogeneic cells  because mitomycin-treated 
rather than ~/-irradiatod  stimulator cells  were used. 
reported, it was of interest to study the three major H-2 s strains,  A.SW, B10.S, 
and  SJL/J in this regard.  Results in Table III demonstrate  very little  if any 
stimulation of A.SW or BI0.S LN cells by SJL/J spleen cells, even at ratios of 
1:1; neither did A.SW or B10.S spleen cells stimulate SJL/J LN cells (data not 
shown).  This  did  not  suggest  any  great  proliferation  to  Mls-locus  antigens 
within the H-2 s strains and this topic was therefore not pursued further. 
Although in both of the other H-28 strains, RCS cells induced proliferation at 
ratios of 1:4 (RCS cells to normal LN cells), the response in SJL/J cells to RCS 
was invariably higher. This suggested an influence of the genetic background on 
the responsiveness of the LN cells to RCS, particularly  in the B10.S mice.  In 
further studies, LN cells from the recombinant strains A.TH and A.TL were also 
tested  for  responsiveness  to  RCS-5.  It  was  found that  A.TH  cells  responded 
approximately  equally  well  as  SJL/J  cells,  whereas  A.TL  showed  lower re- 
sponses to RCS even than to normal  SJL/J spleen cells (Table III). It was also 
shown that RCS cells induced good responses in BALB/c LN cells, suggesting 
the presence of allogeneic mixed lymphocyte reaction (MLR)-inducing antigens 
on the lymphoma cell surface (data not shown). 
Study of Surface Antigens of RCS Cells.  In view of the fact that RCS cells 
induced good MLR in BALB/c cells, it was of interest to determine whether RCS 
cells expressed Ia antigens on their surface. Both the single-stage and two-stage 
cytotoxicity tests were performed on gradient-separated,  low density RCS cells 
with  serially  diluted  anti-Ia  sera  of various  specificities  and  rabbit  C.  The 
antisera containing anti-Ia4 with or without anti-Ia5 and/or anti-Tla reactivity 
all  caused  approximately  60%  lysis  of RCS-5  (as  well  as  RCS-19)  cells  with 
maximal  effectiveness up to dilutions of 1:640. Under similar conditions,  only 
about 32% of normal  SJL/J LN cells were killed,  while anti-Thy  1.2 killed an 
average  of 18%  RCS cells  and  67%  normal  LN cells  (Table IV).  Rabbit anti- 
mouse Fab killed 11% RCS cells and an average of 36% normal LN cells. 
Since many murine tumors show viral antigens on their surface and since it 
has  been  demonstrated  recently  that  many  anti-Ia  sera  contain  antibody  to 
leukemia  virus antigens  (22,  23),  it seemed important  to determine  whether 
RCS-5 cells expressed these  surface antigens.  It was found that  neither  goat 
anti-murine  leukemia  virus  (MuLV) gp69/70  nor rabbit  anti-MuLV  gs30 had 
any cytotoxic effect on RCS cells even in dilutions of <1:20 (Table IV). Rat anti- PONZIO,  DAVID,  SHREFFLER,  AND  THORBECKE 
TABLE  IV 
Presence of Ia Antigens on the Surface  of RCS Cells of SJL/J Mice 
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Antisera* + C  Specificities detected 
% Cytotoxicity$  with: 
Normal 
RCS cells  SJL/J  LN 
cells 
Anti-Ia serum 
(A.TL × B10.M)F~ anti-A.TH  Ia.4; Tla 
A.TL anti-A.TH  Ia.4, 5; Tla 
(A.TL × 5R)F~ anti-A.TH  Ia. 4, 5 
(A.TL x A.TFR3)F~ anti-A.TH  Ia.4 
(A.AL × B.10)F~ anti-A.TL  H-2.19 
(A.TH  × B.10M)F~ anti-A.TL  Ia.1, 2 
61  37 
61  32 
60  37 
66  55 
69  71 
20 
Anti-Thy 1.2  8C3H  18  67 
Rabbit anti-mouse Ig  Fab  11  36 
Goat anti-MULV  gp 69/70  10  11 
Rabbit anti-MuLV  gs 30  9  11 
Rat anti-MuLV  NTD Gross virus  14  10 
Rabbit anti-xenotrophic virus  Anti-NZB virus  20 
Rabbit anti-xenotrophic  virus  Anti-BALB/c virus  15 
* All normal sera, including  SJL/J, A.TL, rabbit, and rat gave <11% cytotoxicity. 
Values given represent the mean of 3-10 separate determinati~bns. Dilutions of anti-Ia and 
anti-Thy 1.2 sera for which results are given are 1:320 or 1:640. All negative sera were 
tested as low as 1:20 or 1:40 as well as at higher dilutions;  values given for negative sera 
are with lowest dilution tested. 
MuLV also failed to show significant cytotoxicity. At a  dilution of 1:40, it killed 
14%, and at 1:160  <10% of RCS. This relatively high background was, however, 
not due to the presence of MuLV on tumor cells since absorption of known rat 
anti-MuLV  sera  with  RCS-5  cells  failed  to  remove  any  antibody  to  MuLV 
proteins,  whereas absorption with normal SJL/J thymus cells did  (E.  Stockert 
and N.  M.  Ponzio, unpublished  observations). 
Another  group  of viruses  which  is  relatively ubiquitous  in  different  mouse 
strains  such  as  NZB  and  BALB/c consists  of the  so-called xenotropic viruses. 
Recently,  Morse et al.  found xenotropic viral protein on the surface of a  small 
percentage of SJL/J spleen cells (H. C. Morse, III, T. Chused,  B. Mathieson,  T. 
Sharp, M. Boehm-Truipp, and J. Hartley, unpublished results). For this reason, 
cytotoxicity  studies  with  antisera  to  xenotropic  viruses  were  also  performed. 
They failed to show significant cytotoxicity above background at dilutions as low 
as 1:20  (Table IV). 
Pretreatment  of RCS cells with  anti-Ia sera and  C  effectively reduced their 
ability to  induce  a  proliferative response in  syngeneic LN cells.  As shown  in 
Table V, cells remaining after removal of killed cells induced only 23-51% of the 
original  response,  while  cells surviving treatment  with either anti-Thy  1.2  or 
with  anti-Ig plus  C  retained  full  capacity to  induce  stimulation.  In  contrast, 
pretreatment of responding LN cells with anti-Ia antisera plus C  had no effect 
on their ability to respond,  whereas anti-Thy 1.2 plus C abolished their respon- 
siveness (Table VI). Incubation of RCS cells or SJL/J LN cells with anti-Ia sera 138  SJL/J  T-CELL  PROLIFERATION  TO  Ia-BEARING  SYNGENEIC  RCS 
TABLE  V 
Remaining Stimulatory Capacity to SJL/J LN Cells of RCS Cells 
Pretreated with Various Antisera and C 
Pretreatment of stimula-  h cm$  % of control re- 
tor X-RCS-5*  Exp. 1  Exp. 2  sponse 
Untreated  11,372  12,766 
Anti-Ia.4 (Tla)  + RC'  2,516  23.0 
Anti-Ia.4, 5 (Tla)  +  RC'  3,532  32.3 
Anti-Ia.4 +  RC'  5,562  50.9 
Anti-Thy 1.2  +  RC'  11,925  109.2 
NMS +  RC'  10,919  100.0 
RC'  11,393 
Anti-Ig +  GPC'  6,397  82.1 
NRS +  GPC'  7,790  100.0 
* 2 × 105 LN cells plus 105 stimulator cells per well. Stimulator cells (6.6 × 10s/ 
ml) were incubated  in the presence of anti-Ia (hl00),  anti-Thy 1.2  (1:60), 
anti-Ig (1:30), normal SJL (NMS;  1:100), or normal rabbit (NRS; 1:30) sera 
and either rabbit C (RC') (1:18)or guinea pig C (GPC') (1:15). Anti-Ia.4 (Tla) 
=  (A.TL × B10.M)F1 anti-A.TH; anti-Ia.4, 5 (Tla)  = A.TL anti-A.TH; anti- 
Ia.4 =  (A.TL =  A.TFR3)F, anti-A.TH. 
A cpm = (cpm of mixed cell culture) -  (cpm of responder cells alone + cpm of 
stimulator cells alone). 
TABLE  VI 
Pretreatment of Responder SJLM LN Cells with Anti-Ia Sera and 
Rabbit C Does not Alter Their Proliferative Response to RCS* 
Pretreatment of re-  A cpm§  % of control re- 
sponder SJL/J LN cells$ 
(2  ×  105)  Exp.  1  Exp. 2  sponse 
Normal mouse sera + RC  11,073  7,866  100 
Anti-Ia.4 (Tla)  + RC  13,586  123 
Anti-Ia.4, 5 (Tla)  + RC  12,433  112 
Anti-Ia. 4 +  RC  10,771  97 
Anti-Thy 1.2  -  588  8 
* 2  ×  105 responder SJL/J LN cells were cultured with 5  ×  104 T-irradiated 
(6,000 R) RCS cells for 96 h, the last 24 of which were in the presence of 1 ~Ci 
3H-thymidine. 
Cells (6.6 × 106/ml) were incubated at 37°C for 45 rain in the presence of anti- 
Ia (1:100) or normal SJL (NMS; 1:100) sera and rabbit C (RC) (1:18). Specific 
antisera as in Table V. 
§ h cpm as in Table V. 
in the absence of C  before culture did not diminish their subsequent  ability to 
stimulate  or to respond,  respectively (data not shown). 
Inclusion  of anti-Ia  sera  without  C  in  the  culture  media  inhibits  unidirec- 
tional MLC (24,  25).  In these experiments, it was demonstrated  that the inhibi- 
tion is due to specific reactivity of anti-Ia sera with the stimulator and not with 
the responder cell. Data presented in Table VII indicate a  similar inhibition of 
the  proliferative response  of SJL/J  LN cells to  RCS tumor  cells when  anti-Ia 
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TABLE VII 
Inhibition by Various Anti-Ia Sera of the Proliferative  Response* of SJL/J LN Cells to 
RCS 
% Mouse  cpm in con-  % of control*  response in presence of antisera§ 
trol culture  A.TL x  A.TL anti-  A.TLA.TFR3X  A.TL x 5R  B10A'ALanti-  ×  B10A'THanti-  ×  Exp.  Stimulus  serum  with NMS  B10,M  A.TH  A.TL  A.TL 
no.  added  (100%)$  anti-A.TH  anti-A.TH  anti-A.TH 
X-RCS  1.0  23,855  29  46  58 
X-RCS  2.5  19,312  4  29  44 
X-RCS  5.0  17,296  9  5  15 
X-RCS  3.0  7,177  14  60 
X-BALB/c  3.0  6,548  71  70 
Spleen 
Con A  3.0  14,400  52  55 
PHA  3.0  1,538  120  123 
3  X-RCS  3.0  11,959  40  52  43  109  114 
X*BALB/e  3.0  6,653  94  56  112  125  115 
Spleen 
Con A  3.0  6,003  291  176 
PHA  3.0  4,030  151  135 
LPS  3.0  4,025  119  49 
* 2 x  105 SJL/J LN cells were cultured in microplatos with Con A, PHA, LPS, 5 x  104 RCS cells (6,000 R), or 2 x 10  s BALB/c spleen 
cells (1,500 R) in the presence of  the indicated percentage of anti-Ia serum in 0.2 nd RPMI 1040 with 10% fetal calf  serum for 72 or 
96 h  (RCS and BALB/c spleen cells; exp.  1 and 2).  1 pCi of SHothymidine  was added for the last 24 h of culture, 
~: (A.TL x  B10.M)Fz anti-A.TH -  specificity, anti-Ia.4 anti-Tla. A.TL anti-A.TH -  specificity, anti-Ia, 4, 5 anti-Tla.  (A.TL  x 
A.TFRs)F1 anti-A.TH -  specificity, anti-Ia.4.  (A.TL x  5R)FI anti-A.TH -  specificity, anti-Ia.4. (A.AL x  B10)F~ anti-A.TL - 
specificity, anti-H-2.19.  (A.TH x  B10)Fz anti-A.TL -  specificity, anti-Ia.1, 2. 
§ cpm of stimulated cultures containing I% NMS were equal to those without NMS (exp.  1). Background cpm were reduced from 
982 to 150, 63, and 47 by 1.0, 2.5, and 5.0% NMS, respectively (exp. 1), from 72 to 5 with all anti-Ia sera at 72 h and from 259 to 20 at 
96 h  (exp.  2), and from 1,178 to 200 with control and anti-Ia sera at 96 h  (exp.  3). 
inhibition with three different antisera and almost total inhibition at 5%, when 
compared to cultures containing similar percentages of normal mouse serum 
(exp.  1).  As  with  allogeneic MLC,  the  block  appeared  to  occur on  the  RCS 
stimulator cell since the response to nonspecific T-cell stimulators such as PHA 
remained unaffected. The partial inhibition ofconcanavalin A (ConA) responses 
(exp. 2) and of lipopolysaccharide (LPS) responses (exp. 3) are in keeping with 
reports of others (26, 27). Inhibition of LPS responses have also been noted with 
5% normal mouse sera  (28) but at the 3% concentration studied here such an 
inhibition was not seen with normal control sera. 
It would appear that inhibition of  the response to RCS by anti-Ia  s is specific for 
that response since the one to allogeneic BALB/c spleen cells showed much less 
of a  reduction in both exps.  2  and 3.  In exp.  3,  additional control sera were 
included, such as normal A.TL, which showed no inhibition of any responses, 
and antiserum to H-2K', as well as antiserum to Ia  k.  Neither of these latter 
antisera inhibited the response to RCS cells or to BALB/c cells (Table VII). 
Discussion 
Stimulation of normal SJL/J T  cells is apparently induced by all syngeneic 
RCS cells whether derived from primary, as shown here, or from transplanted 
(1) tumors or even from in vitro cell lines developed from RCS (29). The most 
actively stimulating cells appeared to be those of low density, but all density 140  SJL]J  T-CELL  PROLIFERATION  TO  Ia-BEARING  SYNGENEIC  RCS 
fractions contained stimulating  cells; evidence for a  soluble stimulating factor 
produced or liberated from these tumor cells was not seen. 
The height of the response for LN cells was several-fold that of allogeneic cells 
(Table III), suggesting the notion of presensitization of the SJL/J T cells to some 
antigen  on the tumor cells.  However, the fact that  adult thymus cells (1) and 
even thymus cells of neonatal SJL/J mice already give proliferative responses to 
RCS  ~ does not support this idea. The response is also much higher than that of 
thymus or spleen to syngeneic normal LN cells in the SJL/J strain (1). However, 
responses to LPS-induced normal SJL/J blast cells are seen with syngeneic LN 
cells, 2 and a  similarity between this type of proliferation and that to RCS cells 
warrants consideration. Another strikingly similar phenomenon is found in the 
responsiveness of human peripheral T cells to lymphoid tissue culture cell lines 
(9),  mitogen-induced  blast  cells  (30),  and  even  normal  B  cells  (31,  32)  from 
autologous individuals. 
The possibility that an ecotropic or xenotropic virus on RCS cells induced the 
stimulation  of T  cells was investigated,  but no positive results were obtained. 
Although  it is known that  a  wide variety of inbred strains  naturally produce 
antibody against endogenous ecotropic leukemia virus (MuLV) (33, 34), there is 
no evidence that MuLV was present on RCS cells since such tumor cells did not 
absorb  activity  from  anti-G~×  sera  while  normal  SJL  thymus  cells  did  (E. 
Stockert and N. M. Ponzio, unpublished observations). While xenotropic virus is 
found on  SJL/J  spleen  cells  (H.  C.  Morse,  III,  T.  Chused,  B.  Mathieson,  T. 
Sharp,  M.  Boehm-Truipp,  and  J.  Hartley,  unpublished  results),  preliminary 
results do not indicate its presence on RCS cells since these were not killed by 
rabbit antiserum to xenotropic virus plus C (F. Weinbaum, H. C. Morse, and N. 
M. Ponzio, unpublished observations) and there was no blocking in vitro of the 
proliferative  response  to  RCS  in  the  presence  of antisera  to  xenotropic  or 
ecotropic virus. 
The ability of Ia antigens to induce MLR (24, 35) and their importance in the 
presentation of other antigens to helper T cells, particularly in the proliferative 
response  (36-38),  prompted us to look for the presence of Ia antigens  on RCS 
cells.  Evidence that  these lymphoma cells do exhibit Ia surface antigens  was 
readily obtained. In the first place, RCS cells were found to induce good MLR in 
cells from allogeneic (BALB/c) mice. Secondly, RCS cells were killed to approxi- 
mately  60%  by  anti-Ia  plus  C  and  the  stimulating  cells  were  particularly 
sensitive  to  this  cytotoxic effect since  removal  of anti-Ia  killed  cells  greatly 
reduced the  ability of RCS to induce proliferation.  Finally,  the  ability of the 
anti-Ia4  antisera  to block, consistently,  in vitro responsiveness to RCS, while 
leaving other T-cell responses intact, provided strongly suggestive evidence that 
the  major  determinant  inducing  T-cell  proliferation  to  RCS  is  either  the  Ia 
antigen  itself or something  else closely associated with Ia.  Modification of Ia 
surface antigen on RCS cells could, for instance, be the result of a virus infection 
of unknown nature, or of continued proliferation of the tumor cells which might 
also lead to changes  in the  surface Ia expression.  There  might  be something 
peculiar about the way Ia antigen is exposed on the surface of these cells that 
happens to be particularly stimulating to T cells. 
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stimulating autologous T cells because the response may represent an exagger- 
ated form of a normal autostimulation process. Kuntz et al. (32) have shown that 
a subpopulation of nylon wool adherent, Fc-positive cells stimulates nylon wool 
nonadherent autologous T cells of human peripheral blood. The present findings 
may reflect a  similar  phenomenon  in  the  mouse in the  sense that  RCS cells 
might represent a  tumor of such a  stimulating B-cell subpopulation.  An addi- 
tional argument in favor of these considerations is that both the stimulation of 
neonatal  thymus  by  syngeneic  adult  spleen  cells  (39)  and  of human  T  by 
autochthonous "non-T" peripheral blood cells (M. E. Weksler, personal commu- 
nication) are inhibited by antibodies to Ia antigens. 
Since macrophage populations also express Ia antigens  (40),  it was possible 
that  the  anti-Ia  sera  utilized  in  these  experiments  were blocking  responses 
through reactivity with Ia determinants on macrophages presenting a stimulat- 
ing  moiety.  However,  in  separate  experiments, 2 in  which  macrophages  were 
depleted by removal of nylon wool adherent  cells from both the responder LN 
population and from the RCS stimulator cell suspension,  no diminution of the 
proliferative response was observed. These data indicate that the proliferation 
induced by RCS in syngeneic T cells is independent  of the presence of macro- 
phages, and further support the contention that anti-Ia sera blocks at the RCS 
stimulator cell level. 
The distribution of T-cell responsiveness to RCS cells over the different H-2 s 
strains  was also of interest.  The fact that  SJL/J, A.SW,  and B10.S, which all 
have a  complete H-2 ~ but differ in background genotype, all responded to RCS 
although  to  varying  degrees  may,  of course,  relate  to  the  presence  of some 
unknown virus in these strains.  However, it does indicate a peculiar reactivity 
to the RCS-Ia antigen in all H-2 s strains,  since responses to normal SJL/J cells 
were virtually absent. A.TL and A.TH differ only in the middle portion of the H- 
2 region, including the I, S, and G regions. While A.TL cells failed to respond to 
RCS,  A.TH  cells  were  almost  as  reactive  as  SJL/J  cells  themselves.  This 
indicates that identity between stimulator and responding cells in the K  region 
of H-2  is  not  sufficient,  but  that  identity  in  both K  and  I  regions  confers 
responsiveness to the T cells. The response may thus be a unique function of the 
I  region alone or of the K  and I  region combined. 
These findings support an interesting parallel with that of Zinkernagel  and 
Doherty (41),  Gardner et al.  (42),  and Shearer (43) who demonstrate a  require- 
ment for identity in the H-2  K  or D  regions  in  conjunctions  with  exogenous 
antigenic determinants for the recognition of target cells by cytotoxic effector T 
cells.  It  is  now  apparent  that  there  may  be  two  distinct  lineages  of T-cell 
recognition: one stimulated by the H-2K- and H-2D-associated antigens [Ly 1.2, 
2 and 2,3 (44)] and the other stimulated to proliferate in response to Ia antigen- 
associated  products  [Ly  1.2,  1  (45)].  In  addition,  recent  evidence  has  been 
reported (46) which suggests that the phenotype of cells cytotoxic for syngeneic 
tumor cells is Ly 1+ and Ly 2,3+. In the case of RCS stimulation of syngeneic T 
cells, some sort of tumor-associated antigen  may be recognized in combination 
with the Ia cell surface component, but further studies are needed to identify the 
responsive T-cell  subpopulation.  The requirement  for identity in the I  region 
between stimulator  and  responder  cells is also reminiscent  of the restrictions 142  SJL/J  T-CELL  PROLIFERATION  TO  Ia-BEARING  SYNGENEIC  RCS 
placed by Ir gene products on T-B cell interaction in the immune response (47), 
particularly since RCS lines may represent early B-cell tumors. Previous studies 
on  localization  of radiolabeled  RCS  cells  in  SJL/J  mice  (11)  have  shown  a 
tendency of these cells to localize in follicles of spleen and LN, suggesting a  B- 
cell nature of this tumor, but to date all other B-cell markers, such as surface Ig 
and Fc receptors, have been found to be absent from RCS cells. 
It should be noted that anti-Ia4 is the only major cytotoxic antibody present in 
some of the  antisera  which  killed  a  large  percentage  of the  RCS cells.  This 
antigen  is known to be present predominantly  on B  cells, but also on macro- 
phages (40, 48) and on a subpopulation of T cells (27). These antisera could also 
contain  antibody  to  the  recently  described I-J  region  antigens  expressed  on 
suppressor T cells (49, 50). Further studies will be carried out using specific anti- 
I-J  s sera to determine whether RCS cells or the responding T  cells bear these 
antigens. 
Summary 
The results of studies on the reticulum cell sarcoma  (RCS) tumors of SJL/J 
mice presented  here,  indicate  that  spontaneous tumors,  which  arise  in  older 
mice, also possess the capacity to induce the vigorous proliferative response in 
syngeneic T lymphocytes that are characteristic of the transplantable RCS lines. 
Analysis of cell surface antigens  revealed the presence of Ia determinants  on 
gradient-purified  transplantable  RCS tumor cells; however, these cells did not 
express Thy 1.2,  Ig, or any of the viral proteins that were tested for by specific 
antisera.  Pretreatment  of RCS cells with anti-Ia sera and complement-deleted 
cells that were stimulatory for syngeneic T lymphocytes, and addition of anti-Ia 
sera  directly  to cultures  blocked the  proliferative  response  at the  stimulator 
(RCS) cell level. 
Lymph node cells from H-2 ~ strains  other than  SJL/J, including  A.SW and 
B10.S also gave proliferative responses to RCS cells, although lower in magni- 
tude. A requirement on the part of responding cells for identity with RCS cells at 
the Ir region was indicated by the finding that A.TH but not A.TL lymph node 
cells  responded  to  RCS.  It  is  concluded  that  RCS  cells  stimulate  /r-region 
identical T cells (without evidence of presensitization) through a modification in 
the expression of Ia antigens on the surface of the tumor cells. 
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